Drug‑discovery platform combining AI‑based molecular dynamics analysis with NMR‑based structural/dynamics profiling to characterize flexible, hard‑to‑crystallize targets and enable modality‑agnostic therapeutic discovery. Supports development of therapeutics, diagnostics and biomarkers (applied to ALS screening) and aids translation of academic drug seeds such as antibody mechanism studies for AVWS and Phase‑1 trial preparation.